Bristol Myers Squibb Co. (BMY)
59.59
+0.78
(+1.33%)
USD |
NYSE |
Oct 06, 16:00
59.74
+0.15
(+0.25%)
Pre-Market: 07:21
Bristol Myers Squibb Gross Profit Margin (Quarterly) : 67.95% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 67.95% |
| March 31, 2026 | 66.29% |
| December 31, 2025 | 66.24% |
| September 30, 2025 | 66.00% |
| June 30, 2025 | 65.78% |
| March 31, 2025 | 65.53% |
| December 31, 2024 | 60.15% |
| September 30, 2024 | 55.64% |
| June 30, 2024 | 55.74% |
| March 31, 2024 | 55.54% |
| December 31, 2023 | 56.57% |
| September 30, 2023 | 56.72% |
| June 30, 2023 | 54.60% |
| March 31, 2023 | 57.48% |
| December 31, 2022 | 64.05% |
| September 30, 2022 | 53.99% |
| June 30, 2022 | 57.15% |
| March 31, 2022 | 58.04% |
| December 31, 2021 | 60.02% |
| September 30, 2021 | 58.23% |
| June 30, 2021 | 57.34% |
| March 31, 2021 | 54.98% |
| December 31, 2020 | 56.37% |
| September 30, 2020 | 52.77% |
| June 30, 2020 | 49.85% |
| Date | Value |
|---|---|
| March 31, 2020 | 44.99% |
| December 31, 2019 | 55.57% |
| September 30, 2019 | 70.23% |
| June 30, 2019 | 70.19% |
| March 31, 2019 | 69.05% |
| December 31, 2018 | 71.74% |
| September 30, 2018 | 71.02% |
| June 30, 2018 | 71.98% |
| March 31, 2018 | 69.36% |
| December 31, 2017 | 68.93% |
| September 30, 2017 | 70.23% |
| June 30, 2017 | 73.04% |
| March 31, 2017 | 74.78% |
| December 31, 2016 | 70.04% |
| September 30, 2016 | 73.49% |
| June 30, 2016 | 76.64% |
| March 31, 2016 | 79.09% |
| December 31, 2015 | 72.08% |
| September 30, 2015 | 74.83% |
| June 30, 2015 | 76.34% |
| March 31, 2015 | 78.84% |
| December 31, 2014 | 77.36% |
| September 30, 2014 | 72.20% |
| June 30, 2014 | 74.70% |
| March 31, 2014 | 74.78% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 68.73% |
| Eli Lilly & Co. | 85.78% |
| Merck & Co., Inc. | 71.51% |
| Pfizer Inc. | 62.94% |
| AstraZeneca PLC | 76.09% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 47.80% |
| Return on Assets | 10.18% |
| Return on Invested Capital | 13.74% |
| Profit Margin (Quarterly) | 25.54% |
| Operating Margin (Quarterly) | 36.04% |
| Return on Net Operating Assets | 14.85% |